Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial Wrinkles
A Randomized, Evaluator-Blinded Clinical Study to Evaluate the Efficacy and Tolerability of an Investigational Light Therapy Mask on Subjects With Mild to Moderate Mottled Hyperpigmentation and Moderate to Severe Facial Wrinkles
1 other identifier
interventional
124
1 country
1
Brief Summary
This research study will test how well a light therapy mask works for women with mild to moderate hyperpigmentation (brown spots) and moderate to severe facial wrinkles, as compared to a "sham" or inactive investigational light therapy mask. The study will also test if the light therapy mask causes any irritation. For the first 12 weeks of the study, participants will use the assigned mask, along with a provided cleanser and sunscreen. For the second 12 weeks of the study, participants will use just the cleanser and sunscreen.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2017
CompletedStudy Start
First participant enrolled
October 9, 2017
CompletedFirst Posted
Study publicly available on registry
October 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 6, 2018
CompletedResults Posted
Study results publicly available
March 5, 2019
CompletedMarch 5, 2019
February 1, 2019
3 months
October 6, 2017
January 4, 2019
March 4, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Global Wrinkling - Change From Baseline to Week 12, Averaged Expert Grader Scores
3 Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.
Baseline to Week 12
Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 1
Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 1 were calculated individually.
Baseline to Week 12
Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 2
Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 2 were calculated individually.
Baseline to Week 12
Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 3
Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 3 were calculated individually.
Baseline to Week 12
Secondary Outcomes (31)
Global Wrinkling - Change From Baseline to Week 1
Baseline to Week 1
Global Wrinkling - Change From Baseline to Week 4
Baseline to Week 4
Global Wrinkling - Change From Baseline to Week 24
Baseline to Week 24
Fine Lines - Change From Baseline to Week 1
1 week
Fine Lines - Change From Baseline to Week 4
Baseline to Week 4
- +26 more secondary outcomes
Study Arms (2)
Active Cell: Active Mask
EXPERIMENTALCleanser, Moisturizer, Active Mask
Sham Cell: Sham Mask
SHAM COMPARATORCleanser, Moisturizer, Sham Mask
Interventions
A facial cleanser will be used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF will be applied full-face. For the first 12 weeks of the study, the active light therapy mask will be used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage will be discontinued.
A facial cleanser will be used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF will be applied full-face. For the first 12 weeks of the study, the sham light therapy mask will be used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage will be discontinued.
Eligibility Criteria
You may qualify if:
- Has mild to moderate brown spots
- Has moderate to severe facial wrinkling
- Able to read, write, speak, and understand English
- In general good health
- If capable of having a child: must agree to practice a medically acceptable form of birth control.
- Intends to complete the study and willing to follow all study directions.
You may not qualify if:
- Allergies/sensitivity to skincare products or the test product ingredients
- Has a light or photosensitivity disorder or another medical condition that could increase risk to the subject or confuse the study results.
- Is taking medication that may cause skin sensitivity to light
- Has been using a product or medication that the study investigator determines will increase health risk to the subject or confuse the study results
- Has a facial skin condition (e.g. rosacea, acne, eczema, etc.) that could increase health risk to the subject or confuse the study results.
- Has skin cancer or a history of skin cancer.
- Has an immune deficiency disorder, active hepatitis, or an autoimmune disease.
- Has an uncontrolled metabolic condition (e.g. diabetes, hypertension)
- Is pregnant, nursing, or planning to become pregnant.
- Plans to start or change a hormone replacement therapy during the study.
- Has participated in another study in the past 30 days or plans to during the study.
- Is an employee or relative of the Study Site, Investigator, or Sponsor.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
KGL Skin Study Center, LLC
Broomall, Pennsylvania, 19008, United States
Related Publications (6)
Fitzpatrick RE. Laser resurfacing of rhytides. Dermatol Clin. 1997 Jul;15(3):431-47. doi: 10.1016/s0733-8635(05)70452-6.
PMID: 9189680BACKGROUNDMcCullough JL, Kelly KM. Prevention and treatment of skin aging. Ann N Y Acad Sci. 2006 May;1067:323-31. doi: 10.1196/annals.1354.044.
PMID: 16804006BACKGROUNDWeiss RA, McDaniel DH, Geronemus RG. Review of nonablative photorejuvenation: reversal of the aging effects of the sun and environmental damage using laser and light sources. Semin Cutan Med Surg. 2003 Jun;22(2):93-106. doi: 10.1053/sder.2003.50008.
PMID: 12877228BACKGROUNDKim JW. Clinical trial of nonthermal 633 nm Omnilux LED array for renewal of photoaging: clinical surface profile metric results. Korea Soc Las Med Surg. 2005; 9:69-76.
BACKGROUNDFitzpatrick RE, Goldman MP, Satur NM, Tope WD. Pulsed carbon dioxide laser resurfacing of photo-aged facial skin. Arch Dermatol. 1996 Apr;132(4):395-402.
PMID: 8629842BACKGROUNDGriffiths CE, Wang TS, Hamilton TA, Voorhees JJ, Ellis CN. A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol. 1992 Mar;128(3):347-51.
PMID: 1550366BACKGROUND
Results Point of Contact
- Title
- Sidney Hornby
- Organization
- Johnson & Johnson Consumer Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Stuart Lessin, M.D.
KGL Skin Study Center, LLC
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 6, 2017
First Posted
October 17, 2017
Study Start
October 9, 2017
Primary Completion
January 12, 2018
Study Completion
April 6, 2018
Last Updated
March 5, 2019
Results First Posted
March 5, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share